Goldman Sachs Starts Crinetics (CRNX) at Neutral
Tweet Send to a Friend
(Updated - July 10, 2025 5:21 AM EDT)
Goldman Sachs analyst Richard Law initiates coverage on Crinetics (NASDAQ: CRNX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Richard Law initiates coverage on Crinetics (NASDAQ: CRNX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


